Gerstein, H. C. and Sattar, N. (2022) Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status. Lancet Diabetes and Endocrinology, 10(12), pp. 831-832. (doi: 10.1016/S2213-8587(22)00313-8) (PMID:36372068)
Full text not currently available from Enlighten.
Abstract
No abstract available.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Sattar, Professor Naveed |
| Authors: | Gerstein, H. C., and Sattar, N. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Lancet Diabetes and Endocrinology |
| Publisher: | Elsevier |
| ISSN: | 2213-8587 |
| ISSN (Online): | 2213-8595 |
| Published Online: | 10 November 2022 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details